Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20201
20211
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dimerix Bioscience Pty Ltd2
Amgen1
Boehringer Ingelheim1
Novartis Pharmaceuticals1
Sanofi1
The George Institute1
Travere Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental8
Diabetic Nephropathies2
Glomerulonephritis, IGA2
Kidney Diseases2
Nephrosis, Lipoid2
Glomerulonephritis1
Glomerulonephritis, Membranous1
Nephritis, Hereditary1
Renal Insufficiency, Chronic1

Trials

Showing 76 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.